Fujimoto M - Search Results

1

Clinical significance of soluble CD31 in patients with systemic sclerosis (SSc): association with limited cutaneous SSc.

Sato S, Komura K, Hasegawa M, Fujimoto M, Takehara K. Sato S, et al. Among authors: fujimoto m. J Rheumatol. 2001 Nov;28(11):2460-5. J Rheumatol. 2001. PMID: 11708419

2

Detection of antiribosomal P protein antibodies in patients with systemic sclerosis.

Fujimoto M, Sato S, Takehara K, Nojima Y, Soma Y, Kikuchi K, Ihn H, Igarashi A, Tamaki K. Fujimoto M, et al. Br J Rheumatol. 1995 Oct;34(10):908-11. doi: 10.1093/rheumatology/34.10.908. Br J Rheumatol. 1995. PMID: 7582693

3

Ultrasound measurement of skin thickness in systemic sclerosis.

Ihn H, Shimozuma M, Fujimoto M, Sato S, Kikuchi K, Igarashi A, Soma Y, Tamaki K, Takehara K. Ihn H, et al. Among authors: fujimoto m. Br J Rheumatol. 1995 Jun;34(6):535-8. doi: 10.1093/rheumatology/34.6.535. Br J Rheumatol. 1995. PMID: 7633795

4

Serum aldolase level is a useful indicator of disease activity in eosinophilic fasciitis.

Fujimoto M, Sato S, Ihn H, Kikuchi K, Yamada N, Takehara K. Fujimoto M, et al. J Rheumatol. 1995 Mar;22(3):563-5. J Rheumatol. 1995. PMID: 7783084

5

Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma.

Ihn H, Sato S, Fujimoto M, Kikuchi K, Takehara K. Ihn H, et al. Among authors: fujimoto m. Br J Dermatol. 1996 May;134(5):843-7. Br J Dermatol. 1996. PMID: 8736323

6

Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis.

Hasegawa M, Fujimoto M, Kikuchi K, Takehara K. Hasegawa M, et al. Among authors: fujimoto m. J Rheumatol. 1997 Feb;24(2):328-32. J Rheumatol. 1997. PMID: 9034992

7

Elevated serum tumor necrosis factor-alpha levels in patients with systemic sclerosis: association with pulmonary fibrosis.

Hasegawa M, Fujimoto M, Kikuchi K, Takehara K. Hasegawa M, et al. Among authors: fujimoto m. J Rheumatol. 1997 Apr;24(4):663-5. J Rheumatol. 1997. PMID: 9101498

8

Circulating intercellular adhesion molecule-1 in the sera of patients with systemic sclerosis: enhancement by inflammatory cytokines.

Ihn H, Sato S, Fujimoto M, Kikuchi K, Kadono T, Tamaki K, Takehara K. Ihn H, et al. Among authors: fujimoto m. Br J Rheumatol. 1997 Dec;36(12):1270-5. doi: 10.1093/rheumatology/36.12.1270. Br J Rheumatol. 1997. PMID: 9448587

9

Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis.

Hasegawa M, Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K. Hasegawa M, et al. Among authors: fujimoto m. J Rheumatol. 1998 Feb;25(2):308-13. J Rheumatol. 1998. PMID: 9489824

10

High seroprevalence of Helicobacter pylori infection in patients with systemic sclerosis: association with esophageal involvement.

Yazawa N, Fujimoto M, Kikuchi K, Kubo M, Ihn H, Sato S, Tamaki T, Tamaki K. Yazawa N, et al. Among authors: fujimoto m. J Rheumatol. 1998 Apr;25(4):650-3. J Rheumatol. 1998. PMID: 9558164

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,532 results

Search Page

Filters